Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Digital1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- Transplantation1
Search Results
Sort by
- BookAnkit Saneja, Amulya K. Panda, Eric Lichtfouse, editors.Summary: This edited book comprises of eight chapters dealing on various aspects of pharmaceutical technology for delivery of natural products. Book chapters deal with the solubility and bioavailability enhancement technologies for natural products. Emphasis has also been given on the significance of delivery strategies for improving the therapeutic efficacy of paclitaxel, galantamine and tea constituents.
Contents:
Preface
1. Pharmaceutical technology for improving the of bioavailability of natural products
2. Solubility Enhancement Techniques for Natural Product Delivery
3. Delivery of natural products using polymeric particles for cancer chemotherapeutics
4. Chemistry, pharmacology and therapeutic delivery of major tea constituents
5. Current approaches and recent advances in Galantamine Delivery for Alzheimer's
6. Overview of Paclitaxel Delivery Systems
7. Phytosomes as an emerging nanotechnology for herbal drug delivery
8. Albumin as natural versatile drug carrier and various diseases treatment. - ArticleBitter-Suermann H, Säve-Söderbergh J.Transplantation. 1978 Jul;26(1):28-34.A new technique for transplanting duct-ligated rat pancreas grafts, rather similar to the technique for spleen grafting in rats, is presented. Inbred AGUS and WAG rats with a strong Ag-B incompatibility were used. Duct-ligated pancreas AGUS to AGUS isografts survived indefinitely in streptozotocin-induced diabetic hosts while WAG to AGUS allografts were quickly rejected. However, when WAG spleen and pancreas were transplanted en bloc to AGUS rats, endocrine pancreas graft function persisted for up to 6 weeks. This finding of a transient protection of pancreas allografts by donor-strain spleen allografts led to further experiments. AGUS recipients first received WAG spleen allografts which then were removed after 3 to 5 months, at which time WAG pancreas allografts were inserted. Sixty-eight per cent of these grafts survived and cured their hosts of streptozotocin-induced diabetes.